From the editor

The future is diversity. That is the central, take-home message of our cover feature this month on diversity and inclusion in pharma and healthcare (p16). As John Pinching writes, ‘the totems of difference and parity provide genuine opportunities for tangible change’, and ‘improved outcomes, a greater understanding of the human condition and an environment which includes everyone are all within our reach’. Stephen Frost argues there is still much to be done to achieve a fully inclusive culture in the industry, but notes that diversity is now higher on pharma’s agenda (p20), as clearly shown by our interviews with Certara’s Demetrius Carter and Teva’s Kim Innes on page 19.

Elsewhere (p22), Paul Midgley and Oli Hudson, of Wilmington Healthcare, look at how patients are increasingly being empowered to manage their conditions at home as the coronavirus has eroded the lion’s share of NHS resources, and what lasting impact this might have on the structure of care provision. On page 38, Carsten Wierwille considers how COVID-19 is creating a new normal where healthcare services are designed to offer digital, contactless solutions by default rather than as an alternative to physical interactions.

We also delve deep into science with a really fascinating tour of 3D bioprinting on page 26, showcasing advances in the field and what could be achieved in the next decade, while on page 32 geneticist Jarret Glasscock pits RNA against DNA in a battle of the bases to determine which biomolecule will ‘reign supreme for biomarker discovery’.

Finally, a reminder that the PharmaTimes Marketer of the Year, Communications Team of the Year and Sales Awards are open for entry, while both International and the US Clinical Researcher of the Year competitions are pushing ahead, with finals days to be held virtually for the first time in response to the coronavirus pandemic.

I hope you enjoy the issue!

Selina McKee
editor

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
Selina McKee / editor
selina.mckee@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com   

SALES & MARKETING
Anna Yeardley / business manager
anna.yeardley@pharmatimes.com
Luci Sargood / business manager
luci.sargood@pharmatimes.com
Elliott Skilton / marketing executive
elliott.skilton@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £84.00 UK and £94.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2020 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.